OSLO CANCER CLUSTER SA

Operating

Arbeider for å samle bedrifter, organisasjoner, kompetanse- og utdanningsinstitusjoner innenfor Life Science. Oslo Cancer Cluster representerer en næringsklynge med aktivitet innen kreftdiagnostikk og behandling med støtte fra regionale utviklingsaktører.

Forskningsbasert industricluster innenfor Innovativ Cancer Diagnostikk og Behandling.

Organization

CEO: KF
Ketil Forsland Widerberg1977
Chairman of the board: ØK
Øyvind Kongstun Arnesen1957
Years since formation: 19 years; since Apr 12, 2007
Type: Co-operative
VAT registered: Yes
Number of employees: 9

Financials

Total operating income 2025: 19,192,000; NOK
Annual total result 2025: 469,000; NOK
Total equity 2025: 27,969,000; NOK

Last update: Aug 15, 2026

Management

Management / administration

Name	Role	Shares
KF Ketil Forsland Widerberg 1977	Managing Director/CEO	-

Board

Name	Role	Shares
ØK Øyvind Kongstun Arnesen 1957	Chairman	-
LB Line Bjørge 1966	Board Member	-
GM Gunhild Mari Mælandsmo 1963	Board Member	-
GH Geir Hetland 1966	Board Member	-
RC Renée Christine Amundsen 1978	Board Member	-
TE Tor Even Sogn Nergård 1972	Board Member	-
OA Ole Alexander Opdalshei 1968	Board Member	-
TA Tarje Andre Bergdahl 1968	Board Member	-
SS Sigbjørn Smeland 1961	Board Member	-
JP Jens Petter Berg 1960	Board Member	-
TL Thomas London 1974	Board Member	-
ÅF Åsmund Flobak 1980	Board Member	-

Others

Name	Role	Shares
K KPMG AS	Auditor	-

Last update: Aug 15, 2026

Ownership

Shares owned by the OSLO CANCER CLUSTER SA

Name	Share class	Total number of shares	Share
O OSLO CANCER CLUSTER INCUBATOR AS	Ordinary shares	137,634	59.28 %
H HEALTHCATALYST AS	Ordinary shares	333	33.33 %
O OCCI HOLDING AS	Ordinary shares	18,000	1 %

Last update: Jun 2, 2025

Group structure

OSLO CANCER CLUSTER SA
Total operating income 2025: NOK 19,192,000
Operating profit 2025: NOK -851,000
Employees: 9

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	19,192,000	18,751,000	18,655,000	18,709,000	16,177,000
Annual Total Result	469,000	929,000	2,022,000	2,572,000	736,000
Total assets	36,553,000	37,261,000	37,696,000	31,695,000	37,605,000
Total liabilities	8,584,000	9,761,000	9,175,000	5,196,000	13,678,000
Total equity	27,969,000	27,500,000	28,521,000	26,499,000	23,927,000

P&L

Year	2025	2024	2023	2022	2021
Total operating income	19,192,000	18,751,000	18,655,000	18,709,000	16,177,000
Total operating costs	20,043,000	19,220,000	17,644,000	16,424,000	15,733,000
Operating result	-851,000	-469,000	1,011,000	2,285,000	444,000
Financial income/costs	1,321,000	1,398,000	1,011,000	287,000	292,000
Profit before tax	469,000	929,000	2,022,000	2,572,000	736,000
Total tax & extraordinary income/cost	0	0	0	0	0
Annual Total Result	469,000	929,000	2,022,000	2,572,000	736,000

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	3,965,000	3,965,000	3,965,000	3,965,000	3,865,000
Total current assets	32,589,000	33,296,000	33,732,000	27,730,000	33,741,000
Total assets	36,553,000	37,261,000	37,696,000	31,695,000	37,605,000
Short term debt	8,584,000	9,761,000	9,175,000	5,196,000	13,678,000
Long term debt	0	0	0	0	0
Total liabilities	8,584,000	9,761,000	9,175,000	5,196,000	13,678,000
Contributed capital	0	0	0	0	0
Retained earnings	27,969,000	27,500,000	28,521,000	26,499,000	23,927,000
Total equity	27,969,000	27,500,000	28,521,000	26,499,000	23,927,000
Total equity and liabilities	36,553,000	37,261,000	37,696,000	31,695,000	37,605,000

Classification

21st company classification

BETA

Small company

Type of organization

Co-operative

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2500

Private non-profit institutions serving enterprises

OSLO CANCER CLUSTER SA991 068 503